Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor.

@article{Weibach1991AdjuvantCO,
  title={Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor.},
  author={Lothar Wei{\ss}bach and Joachim H. Hartlapp},
  journal={The Journal of urology},
  year={1991},
  volume={146 5},
  pages={
          1295-8
        }
}
In a prospective randomized trial, 225 patients with stage IIB nonseminomatous testis tumor after radical retroperitoneal lymph node dissection received 2 versus 4 courses (arms 1 and 2, respectively) of adjuvant chemotherapy with cis-platinum, vinblastine and bleomycin. With a median followup of 43 months, a total of 7 relapses occurred; 6 in arm 1 and 1 in arm 2. Three patients died: 2 during adjuvant chemotherapy and 1 of progressive disease. The difference in relapse rates between arms 1… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS

Zur Problematik der Spätrezidive von Hodentumoren

VIEW 29 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Canadian consensus guidelines for the management of testicular germ cell cancer.

  • Canadian Urological Association journal = Journal de l'Association des urologues du Canada
  • 2010

Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2005
VIEW 1 EXCERPT
CITES BACKGROUND